Sumitomo Mitsui Trust Group
EDIT icon

Sumitomo Mitsui Trust Group’s Editas Medicine EDIT Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-355,836
Closed -$4.36M – 1197
2022
Q3 		$4.36M Sell
355,836
-392,717
-52% -$6.12M ﹤0.01% 861
2022
Q2 		$8.86M Sell
748,553
-283,560
-27% -$3.8M 0.01% 819
2022
Q1 		$19.6M Sell
1,032,113
-1,643,122
-61% -$30.5M 0.01% 737
2021
Q4 		$71M Sell
2,675,235
-1,587,337
-37% -$54.6M 0.04% 445
2021
Q3 		$175M Sell
4,262,572
-613,847
-13% -$33.6M 0.11% 205
2021
Q2 		$276M Buy
4,876,419
+653,617
+15% +$24.1M 0.16% 139
2021
Q1 		$177M Sell
4,222,802
-165,341
-4% -$9.42M 0.11% 203
2020
Q4 		$308M Sell
4,388,143
-685,965
-14% -$28.2M 0.2% 117
2020
Q3 		$142M Buy
5,074,108
+76,279
+2% +$2.48M 0.1% 225
2020
Q2 		$148M Sell
4,997,829
-109,848
-2% -$2.87M 0.1% 214
2020
Q1 		$101M Buy
5,107,677
+159,450
+3% +$4.02M 0.09% 243
2019
Q4 		$147M Sell
4,948,227
-10,366
-0.2% -$259K 0.12% 199
2019
Q3 		$113M Buy
4,958,593
+3,443,666
+227% +$85.3M 0.1% 229
2019
Q2 		$37.5M Buy
1,514,927
+792,931
+110% +$18.9M 0.03% 522
2019
Q1 		$17.7M Buy
+721,996
New +$16.3M 0.02% 654

Other funds holding EDIT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Sumitomo Mitsui Trust Group's EDIT Position: Q4 2022 in Review

Sumitomo Mitsui Trust Group sold out of Editas Medicine (EDIT) in Q4 2022, closing a stake of 355,836 shares — an estimated $4.36M sold.

Sumitomo Mitsui Trust Group first reported a position in EDIT in Q1 2019 and held it in 15 quarters. The position peaked at $308M in Q4 2020. 250 funds tracked by Wall St. Rank hold EDIT as of Q4 2022.

  • Sumitomo Mitsui Trust Group reported no remaining Editas Medicine position as of Q4 2022 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 355,836 Editas Medicine shares in Q4 2022, an estimated $4.36M.
  • Sumitomo Mitsui Trust Group first reported a position in Editas Medicine in Q1 2019 and held it in 15 quarters.
  • Sumitomo Mitsui Trust Group's Editas Medicine position peaked at $308M in Q4 2020.
  • 250 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2022.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q4 2022, filed 30 Jan 2023.